[1]
“Non-HDL-C and CRP: A Dual Approach to Unmask Hidden Cardiovascular Risk in Type 2 Diabetic Patients”, Attahadi Med J, pp. 211–215, Jul. 2025, doi: 10.69667/amj.25304.